Korean J Nephrol.  2001 Jan;20(1):4-8.

Formation of the Advanced Glycosylated End-products in the Peritoneum of Streptozotocin Diabetic Rats

• Park MO
• Kim YJ
• Kim YL

Abstract

In diabetic and diabetic renal failure patients on continuous ambulant peritoneal dialysis(CAPD) treatment, the peritoneal membrane and vascular beds are continuously exposed to the high glucose concentration contained in the dialysate and blood. This may lead to the local generation of advanced glycosylated end-products(AGEs), formed from nonenzymatic glycation of proteins and lipids with reducing sugars and have been implicated in many diabetic complications. AGEs is cross linked to the circulating proteins resulting in peritoneal dysfunction and vascular thickening. To elucidate the deposition of AGEs in diabetic rats(n=10) induced by streptozotocin(STZ, 75mg/kg) injection via tail vein and those of age-matched control rats(n=10), peritoneums were examined light microscopically and immunohistochemically with monoclonal antibody specific for AGEs after 5 weeks of disease. Histologically, the peritoneum of the STZ diabetic rats showed mild interstitial fibrosis and no mesothelial alteration, vascular proliferation, compared with age-matched, non-diabetic control group. Immunohistochemical staining with AGEs demonstrated that weakly accumulation in the submesothelial layer, but it was not different from comparison with control group. We speculate that the peritoneum of the STZ-induced diabetic rat did not stain with monoclonal antibody against AGEs after 5 weeks of disease, but long-term experiments may demonstrate significant functional and morphological alterations of peritoneum.

Keyword

Streptozotocin; Rat; AGEs; Peritoneum

MeSH Terms

Animals
Carbohydrates
Diabetes Complications
Fibrosis
Glucose
Humans
Membranes
Peritoneum*
Rats*
Renal Insufficiency
Streptozocin*
Veins
Carbohydrates
Glucose
Streptozocin